Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

The possible impact of Advanced Glycation End products on pregnancy outcome in women with Diabetes Mellitus type 1.

Pertynska-Marczewska M, Cypryk K.

Minerva Endocrinol. 2016 Jun 15. [Epub ahead of print]

PMID:
27304070
2.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

3.

The impact of having siblings - analysis of "hygiene theory" of chronic diseases in patients with type 1 diabetes in population of the Łódz region Hygiene theory and type 1 diabetes.

Żurawska-Kliś M, Lesman J, Pietrzak I, Mianowska B, Szadkowska A, Cypryk K.

Pediatr Endocrinol Diabetes Metab. 2015;20(3):95-100. doi: 10.18544/PEDM-20.03.0008.

PMID:
26615045
4.

Increased expression of immune-related genes in leukocytes of patients with diagnosed gestational diabetes mellitus (GDM).

Wojcik M, Zieleniak A, Zurawska-Klis M, Cypryk K, Wozniak LA.

Exp Biol Med (Maywood). 2016 Mar;241(5):457-65. doi: 10.1177/1535370215615699. Epub 2015 Nov 13.

PMID:
26568332
5.

Family, anthropometric and biochemical factors affecting birth weight of infants born to GDM women.

Swierzewska P, Kosiński M, Wójcik M, Dworacka M, Cypryk K.

Ginekol Pol. 2015 Jul;86(7):499-503.

PMID:
26376526
6.

Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor γ expression.

Wójcik M, Mac-Marcjanek K, Nadel I, Woźniak L, Cypryk K.

Arch Med Sci. 2015 Aug 12;11(4):779-87. doi: 10.5114/aoms.2015.47692. Epub 2015 Jan 14.

7.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

8.

Continuous Glucose Monitoring in Type 1 Diabetes Pregnancy Shows that Fetal Heart Rate Correlates with Maternal Glycemia.

Cypryk K, Bartyzel L, Zurawska-Klis M, Mlynarski W, Szadkowska A, Wilczynski J, Nowakowska D, Wozniak LA, Fendler W.

Diabetes Technol Ther. 2015 Sep;17(9):619-24. doi: 10.1089/dia.2014.0255. Epub 2015 Apr 30.

PMID:
25927286
9.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group.

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

10.

The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM).

Wójcik M, Chmielewska-Kassassir M, Grzywnowicz K, Woźniak L, Cypryk K.

Endokrynol Pol. 2014;65(2):134-42. doi: 10.5603/EP.2014.0019. Review.

11.

Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.

Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, Honka M, Janez A, Krnic M, Lalic N, Martinka E, Rahelic D, Roman G, Tankova T, Várkonyi T, Wolnik B, Zherdova N.

Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9. Review.

12.

The association of leukocyte phosphatidylinositol 3-kinase delta overexpression with gestational diabetes mellitus (GDM).

Wójcik M, Mac-Marcjanek K, Woźniak LA, Nadel I, Lewiński A, Cypryk K.

Endokrynol Pol. 2014;65(1):17-24. doi: 10.5603/EP.2014.0003.

13.

Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective.

Franciscus M, Nucci A, Bradley B, Suomalainen H, Greenberg E, Laforte D, Kleemola P, Hyytinen M, Salonen M, Martin MJ, Catte D, Catteau J; TRIGR Investigators.

Clin Trials. 2014 Apr;11(2):150-8. doi: 10.1177/1740774513510070. Epub 2013 Nov 11.

14.

Exenatide twice daily versus insulin glargine for the treatment of type 2 diabetes in Poland - subgroup data from a randomised multinational trial GWAA.

Matyjaszek-Matuszek B, Lenart-Lipińska M, Rogalska D, Nowakowski A; GWAA Polish Study Group.

Endokrynol Pol. 2013;64(5):375-82. doi: 10.5603/EP.2013.0021.

15.

Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus.

Kosinski M, Knop FK, Vedtofte L, Grycewiczv J, Swierzewska P, Cypryk K, Vilsbøll T.

Regul Pept. 2013 Sep 10;186:104-7. doi: 10.1016/j.regpep.2013.08.002. Epub 2013 Aug 16.

PMID:
23958841
16.

The elevated gene expression level of the A(2B) adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus.

Wojcik M, Zieleniak A, Mac-Marcjanek K, Wozniak LA, Cypryk K.

Diabetes Metab Res Rev. 2014 Jan;30(1):42-53. doi: 10.1002/dmrr.2446.

PMID:
23956030
17.

Use of vitamin D supplements during infancy in an international feeding trial.

Lehtonen E, Ormisson A, Nucci A, Cuthbertson D, Sorkio S, Hyytinen M, Alahuhta K, Berseth C, Salonen M, Taback S, Franciscus M, González-Frutos T, Korhonen TE, Lawson ML, Becker DJ, Krischer JP, Knip M, Virtanen SM; TRIGR Investigators.

Public Health Nutr. 2014 Apr;17(4):810-22.

18.

Adenosine receptors expression is elevated in leukocytes of gestational diabetes mellitus (GDM) subjects--a preliminary study.

Zieleniak A, Cypryk K, Wozniak LA, Bieńkiewicz M, Wójcik M.

Endokrynol Pol. 2012;63(2):110-4.

PMID:
22538749
19.

Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study.

Reaney M, Cypryk K, Tentolouris N, Jecht M, Cleall S, Petzinger U, Koivisto V.

Diabetes Res Clin Pract. 2012 Aug;97(2):231-41. doi: 10.1016/j.diabres.2012.02.024. Epub 2012 Apr 6.

PMID:
22483577
20.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group.

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x. Epub 2012 Jan 17.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk